Comparative efficacy and acceptability of 21 antidepressant drugs for the acute treatment of adults with major…

Worth asking your prescriber how bupropion compares with other first-line antidepressants for your particular symptom pattern, since head-to-head evidence for bupropion is thinner than for some alternatives.

gold standard100/100

Top of the evidence hierarchy, independently funded. how we score evidence

FDA approvedbupropion (Wellbutrin, Zyban, Aplenzin, Forfivo)wellbutrinzybanaplenzinforfivo

In a network meta-analysis of 522 randomized trials (116,477 adults with major depression), bupropion, like all 21 antidepressants studied, was more effective than placebo (odds ratios across drugs ranged from 1.37 to 2.13), although the certainty of evidence for most bupropion comparisons was rated low to very low.

Worth asking

Worth asking your prescriber how bupropion compares with other first-line antidepressants for your particular symptom pattern, since head-to-head evidence for bupropion is thinner than for some alternatives.

What it is FDA approved for

Read off the label. Trial duration and approval year are shown only where they were recorded — never inferred.

  • Major depressive disorder
  • Prevention of seasonal major depressive episodes (seasonal affective disorder)
  • Aid to smoking cessation

Source

Comparative efficacy and acceptability of 21 antidepressant drugs for the acute treatment of adults with major depressive disorder: a systematic review and network meta-analysis — Cipriani A, et al. (2018)

Top-tier peer-reviewed journal

Read the source: https://doi.org/10.1016/S0140-6736(17)32802-7

DOI: 10.1016/S0140-6736(17)32802-7

How this was scored

Study design
Meta-analysis of randomised trials
Funding
Independently funded
Published in
Top-tier peer-reviewed journal
Sample size
116,477
Preregistered
Yes
Conflicts disclosed
Yes
Independent of proponent
Yes
Retracted
No

Read the full scoring rubric, including what it can't tell you.

Published August 19, 2026.

Questions

How strong is the evidence behind this?

Resolv rates this source "gold standard". Top of the evidence hierarchy, independently funded. It scores 100 out of 100 on our published rubric. The score is calculated from recorded facts about the source — study design, funding, publication venue, sample size, preregistration — not typed in by an editor.

What is the source for this?

Comparative efficacy and acceptability of 21 antidepressant drugs for the acute treatment of adults with major depressive disorder: a systematic review and network meta-analysis — Cipriani A, et al. (2018). Published in: Top-tier peer-reviewed journal. DOI: 10.1016/S0140-6736(17)32802-7. The full source is linked on this page so you can read it yourself.

Who paid for this research, and does that matter?

Study design: Meta-analysis of randomised trials. Funding: Independently funded. The researchers were independent of whoever benefits from the result. Industry sponsorship is one of the most reliably measured biases in medicine, which is why funding carries real weight in the score rather than sitting in a footnote.

Is bupropion (Wellbutrin, Zyban, Aplenzin, Forfivo), wellbutrin, zyban, aplenzin, forfivo FDA approved?

Yes — FDA approved for Major depressive disorder, Prevention of seasonal major depressive episodes (seasonal affective disorder), Aid to smoking cessation. Approval is for a specific indication, not for everything the drug is prescribed for.

Is this medical advice?

This is information to bring to your prescriber, not medical advice and not a reason to change anything on your own. Nothing here is an instruction to stop or reduce a medication. If you are in crisis, call or text 988.

This is information to bring to your prescriber, not medical advice and not a reason to change anything on your own. Nothing here is an instruction to stop or reduce a medication. If you are in crisis, call or text 988.